Intrinsic value of Curanex Pharmaceuticals Inc Common Stock (CURX)
Live fair value data for Curanex Pharmaceuticals Inc Common Stock (CURX) is currently unavailable. Please check again shortly.
Current Price: $92.00
Valuation: Overvalued
Confidence: 6.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Curanex Pharmaceuticals Inc Common Stock (CURX) undervalued or overvalued?
Based on the current model output, Curanex Pharmaceuticals Inc Common Stock appears to be overvalued with a downside of 20.00%.
Fair value vs market price — Curanex Pharmaceuticals Inc Common Stock (CURX)
Unlock premium access to view the live fair value comparison against current market price for CURX.
Frequently Asked Questions - CURX
How is CURX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for CURX.
Is CURX undervalued or overvalued right now?
CURX is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for CURX: open their intrinsic value pages.